Immuron Reports Neutralizing Activity Against SARS-CoV-2 Key Points

    NEXT STORY
    Pluristem CEO Issues Shareholder Update on Clinical Programs
    PREV STORY
    Teleflex Announces Positive Data Emphasizing the Effectiveness of the UroLift® System Treatment for Enlarged Prostate Across Broad Patient Populations
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Genesis HealthCare Sells 51% Stake in Chinese Subsidiary GRS-HS to Riswein Health Industry Investment Co., Ltd

    author_avatar
    NASDAQ Market News

    Cephalosporin Market Size to Reach $16.87 Billion by 2027: Allied Market Research

    author_avatar
    NASDAQ Market News

    Myriad Applauds New Consensus Statement From International Expert Panel On Screening Recommendations for Hereditary Prostate Cancer

    SALT LAKE CITY, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a ...

    author_avatar
    NASDAQ Market News